Get access

Stability of human mesenchymal stem cells during in vitro culture: considerations for cell therapy

Authors


Correspondence: R. Binato, Praça da Cruz Vermelha 23, 6oandar ALA C, Divisão de Laboratórios do CEMO, INCA, Rio de Janeiro-RJ, CEP 20.230-130, Brazil. Tel.: +55-21-2506-6691; Fax: +55-21-2509-2121; E-mail: rbgomes@inca.gov.br

Abstract

Ex vivo expansion and manipulation of human mesenchymal stem cells are important approaches to immunoregulatory and regenerative cell therapies. Although these cells show great potential for use, issues relating to their overall nature emerge as problems in the field. The need for extensive cell quantity amplification in vitro to obtain sufficient cell numbers for use, poses a risk of accumulating genetic and epigenetic abnormalities that could lead to sporadic malignant cell transformation. In this study, we have examined human mesenchymal stem cells derived from bone marrow, over extended culture time, using cytogenetic analyses, mixed lymphocyte reactions, proteomics and gene expression assays to determine whether the cultures would retain their potential for use in subsequent passages. Results indicate that in vitro cultures of these cells demonstrated chromosome variability after passage 4, but their immunomodulatory functions and differentiation capacity were maintained. At the molecular level, changes were observed from passage 5 on, indicating initiation of differentiation. Together, these results lead to the hypothesis that human mesenchymal stem cells cultures can be used successfully in cell therapy up to passage 4. However, use of cells from higher passages would have to be analysed case by case.

Ancillary